Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1974
-
Total 13F shares, excl. options
-
1.05B
-
Shares change
-
-20.5M
-
Total reported value, excl. options
-
$117B
-
Value change
-
-$2.28B
-
Put/Call ratio
-
0.85
-
Number of buys
-
958
-
Number of sells
-
-829
-
Price
-
$111.00
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q3 2025
2,188 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q3 2025.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,974 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.05B shares
of 1.24B outstanding shares and own 84.69% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (119M shares), BlackRock, Inc. (116M shares), FMR LLC (60.3M shares), STATE STREET CORP (59.1M shares), Capital World Investors (45.2M shares), Dodge & Cox (30.1M shares), Capital Research Global Investors (30M shares), GEODE CAPITAL MANAGEMENT, LLC (29.9M shares), PRICE T ROWE ASSOCIATES INC /MD/ (26.5M shares), and WELLINGTON MANAGEMENT GROUP LLP (25.6M shares).
This table shows the top 1974 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.